Latest filing published 17 Jul 2025 for LIFECORE BIOMEDICAL, INC. \DE\.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Nelson Obus (senior executive) discloses dealings in 6 companies, chiefly Williams Industrial Services Group Inc., Layne Christensen Co and Lifecore Biomedical, Inc. \DE\. We count 126 filings; the first trade dates from 7 June 2007 and the latest from 15 July 2025.
Both buying and selling appear: 79 purchases worth €9.0M, against 3 sales worth €3.8M. The net balance comes to €5.2M on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 35 share grants and 5 option exercises.
The median purchase comes to €60k. 37 out of 57 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 17 July 2025, the filings show a share grant in Lifecore Biomedical, Inc. \DE\. The clock since the last published purchase (2 September 2022) now reads 1,512 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations